{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,4,19]],"date-time":"2024-04-19T08:35:37Z","timestamp":1713515737479},"reference-count":44,"publisher":"Georg Thieme Verlag KG","issue":"22","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Dtsch Med Wochenschr"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1055\/a-1391-5273","type":"journal-article","created":{"date-parts":[[2021,11,6]],"date-time":"2021-11-06T00:03:52Z","timestamp":1636157032000},"page":"1468-1477","source":"Crossref","is-referenced-by-count":1,"title":["Hepatisch metastasiertes kolorektales Karzinom"],"prefix":"10.1055","volume":"146","author":[{"given":"Thomas J.","family":"Ettrich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Felix J.","family":"H\u00fcttner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christoph","family":"Lisson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cihan","family":"Gani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vikas","family":"Prasad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Seufferlein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"194","published-online":{"date-parts":[[2021,11,5]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1093\/jnci\/djh275","article-title":"Colon cancer survival rates with the new American Joint Committee on Cancer sixth edition staging","volume":"96","author":"J B O\u02bcConnell","year":"2004","journal-title":"J Natl Cancer Inst"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.1200\/JCO.2008.19.9273","article-title":"Patients With Initially Unresectable Colorectal Liver Metastases: Is There a Possibility of Cure?","volume":"27","author":"R Adam","year":"2009","journal-title":"J Clin Oncol"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"3672","DOI":"10.1200\/jco.2007.15.7297","article-title":"Is Hepatic Resection Justified After Chemotherapy in Patients With Colorectal Liver Metastases and Lymph Node Involvement?","volume":"26","author":"R Adam","year":"2008","journal-title":"J Clin Oncol"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"3677","DOI":"10.1200\/JCO.2008.20.5278","article-title":"Improved Survival in Metastatic Colorectal Cancer Is Associated With Adoption of Hepatic Resection and Improved Chemotherapy","volume":"27","author":"S Kopetz","year":"2009","journal-title":"J Clin Oncol"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1097\/SLA.0000000000003848","article-title":"Simultaneous Versus Delayed Resection for Initially Resectable Synchronous Colorectal Cancer Liver Metastases: A Prospective, Open-label, Randomized, Controlled Trial","volume":"273","author":"K Boudjema","year":"2021","journal-title":"Ann Surg"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1056\/NEJMoa1305275","article-title":"Panitumumab-FOLFOX4 treatment and RAS mutations in colorectal cancer","volume":"369","author":"J Y Douillard","year":"2013","journal-title":"N Engl J Med"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1093\/annonc\/mdx175","article-title":"Prognostic and predictive value of primary tumour side in patients with RAS wild-type metastatic colorectal cancer treated with chemotherapy and EGFR directed antibodies in six randomized trials","volume":"28","author":"D Arnold","year":"2017","journal-title":"Ann Oncol"},{"issue":"S 05","key":"ref8","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1093\/annonc\/mdx393.002","article-title":"475OmFOLFOXIRI + panitumumab versus FOLFOXIRI as first-line treatment in patients with RAS wild-type metastatic colorectal cancer m(CRC): A randomized phase II VOLFI trial of the AIO (AIO-KRK0109)","volume":"28","author":"M Geissler","year":"2017","journal-title":"Ann Oncol"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"2207","DOI":"10.1056\/NEJMoa2017699","article-title":"Pembrolizumab in Microsatellite-Instability-High Advanced Colorectal Cancer","volume":"383","author":"T Andr\u00e9","year":"2020","journal-title":"N Engl J Med"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"1862","DOI":"10.1093\/annonc\/mdx119","article-title":"Primary tumor sidedness has an impact on prognosis and treatment outcome in metastatic colorectal cancer: results from two randomized first-line panitumumab studies","volume":"28","author":"N Boeckx","year":"2017","journal-title":"Ann Oncol"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1001\/jamaoncol.2016.3797","article-title":"Prognostic and Predictive Relevance of Primary Tumor Location in Patients With RAS Wild-Type Metastatic Colorectal Cancer: Retrospective Analyses of the CRYSTAL and FIRE-3 Trials","volume":"3","author":"S Tejpar","year":"2017","journal-title":"JAMA Oncol"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1007\/s00384-017-2800-1","article-title":"Final analysis of the randomised PEAK trial: overall survival and tumour responses during first-line treatment with mFOLFOX6 plus either panitumumab or bevacizumab in patients with metastatic colorectal carcinoma","volume":"32","author":"F Rivera","year":"2017","journal-title":"Int J Colorectal Dis"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.1016\/s1470-2045(15)00122-9","article-title":"FOLFOXIRI plus bevacizumab versus FOLFIRI plus bevacizumab as first-line treatment of patients with metastatic colorectal cancer: updated overall survival and molecular subgroup analyses of the open-label, phase 3 TRIBE study","volume":"16","author":"C Cremolini","year":"2015","journal-title":"Lancet Oncol"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1200\/jco.2006.09.0928","article-title":"Phase III trial of infusional fluorouracil, leucovorin, oxaliplatin, and irinotecan (FOLFOXIRI) compared with infusional fluorouracil, leucovorin, and irinotecan (FOLFIRI) as first-line treatment for metastatic colorectal cancer: the Gruppo Oncologico Nord Ovest","volume":"25","author":"A Falcone","year":"2007","journal-title":"J Clin Oncol"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"3401","DOI":"10.1200\/jco.19.01340","article-title":"FOLFOXIRI Plus Panitumumab As First-Line Treatment of RAS Wild-Type Metastatic Colorectal Cancer: The Randomized, Open-Label, Phase II VOLFI Study (AIO KRK0109)","volume":"37","author":"D P Modest","year":"2019","journal-title":"J Clin Oncol"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"4906","DOI":"10.1200\/JCO.2008.17.3781","article-title":"Adjuvant chemotherapy after potentially curative resection of metastases from colorectal cancer: a pooled analysis of two randomized trials","volume":"26","author":"E Mitry","year":"2008","journal-title":"J Clin Oncol"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1200\/JCO.20.02447","article-title":"Primary Tumor Resection Plus Chemotherapy Versus Chemotherapy Alone for Colorectal Cancer Patients With Asymptomatic, Synchronous Unresectable Metastases (JCOG1007; iPACS): A Randomized Clinical Trial","volume":"39","author":"Y Kanemitsu","year":"2021","journal-title":"J Clin Oncol"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1016\/j.jamcollsurg.2009.12.040","article-title":"Survival after hepatic resection for metastatic colorectal cancer: trends in outcomes for 1,600 patients during two decades at a single institution","volume":"210","author":"M G House","year":"2010","journal-title":"J\u00a0Am Coll Surg"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1097\/00000658-199909000-00004","article-title":"Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases","volume":"230","author":"Y Fong","year":"1999","journal-title":"Ann Surg"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1097\/SLA.0b013e3182902b6e","article-title":"One-millimeter cancer-free margin is curative for colorectal liver metastases: a propensity score case-match approach","volume":"259","author":"Z Z Hamady","year":"2014","journal-title":"Ann Surg"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1007\/s13244-017-0558-1","article-title":"Liver segmentation: indications, techniques and future directions","volume":"8","author":"A Gotra","year":"2017","journal-title":"Insights Imaging"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1016\/j.hpb.2016.06.006","article-title":"Measurement of liver function using hepatobiliary scintigraphy improves risk assessment in patients undergoing major liver resection","volume":"18","author":"K P Cieslak","year":"2016","journal-title":"HPB (Oxford)"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1097\/01.sla.0000145965.86383.89","article-title":"A two-stage hepatectomy procedure combined with portal vein embolization to achieve curative resection for initially unresectable multiple and bilobar colorectal liver metastases","volume":"240","author":"D Jaeck","year":"2004","journal-title":"Ann Surg"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/j.hpb.2019.08.005","article-title":"Combined biembolization induces higher hypertrophy than portal vein embolization before major liver resection","volume":"22","author":"B Le Roy","year":"2020","journal-title":"HPB (Oxford)"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1097\/SLA.0b013e31824856f5","article-title":"Right portal vein ligation combined with in situ splitting induces rapid left lateral liver lobe hypertrophy enabling 2-staged extended right hepatic resection in small-for-size settings","volume":"255","author":"A A Schnitzbauer","year":"2012","journal-title":"Ann Surg"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1097\/SLA.0000000000000947","article-title":"Early survival and safety of ALPPS: first report of the International ALPPS Registry","volume":"260","author":"E Schadde","year":"2014","journal-title":"Ann Surg"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1097\/SLA.0000000000002511","article-title":"ALPPS Improves Resectability Compared With Conventional Two-stage Hepatectomy in Patients With Advanced Colorectal Liver Metastasis: Results From a Scandinavian Multicenter Randomized Controlled Trial (LIGRO Trial)","volume":"267","author":"P Sandstrom","year":"2018","journal-title":"Ann Surg"},{"key":"ref29","first-page":"662","volume-title":"Interventionelle Radiologie","author":"R W G\u00fcnther","year":"2019"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1055\/a-0721-1947","article-title":"Updated S3 guidelines \u2013 diagnosis and treatment of colorectal carcinoma: relevance for radiological diagnosis and intervention","volume":"191","author":"T J Vogl","year":"2019","journal-title":"Rofo"},{"key":"ref31","first-page":"317","article-title":"Complications after percutaneous ablation of liver tumors: a systematic review","volume":"3","author":"E Lahat","year":"2014","journal-title":"Hepatobiliary Surg Nutr"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1055\/s-2006-941448","article-title":"Complications of radiofrequency ablation of neoplasms","volume":"23","author":"A A Nemcek","year":"2006","journal-title":"Semin Intervent Radiol"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"djx015","DOI":"10.1093\/jnci\/djx015","article-title":"Local Treatment of Unresectable Colorectal Liver Metastases: Results of a Randomized Phase II Trial","volume":"109","author":"T Ruers","year":"2017","journal-title":"J Natl Cancer Instit"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"6407","DOI":"10.2147\/OTT.S204340","article-title":"Microwave ablation compared with radiofrequency ablation for treatment of hepatocellular carcinoma and liver metastases: a systematic review and meta-analysis","volume":"12","author":"M B Glassberg","year":"2019","journal-title":"Onco Targets Ther"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1002\/bjs.10447","article-title":"Long-term outcomes of radiofrequency ablation combined with hepatectomy compared with hepatectomy alone for colorectal liver metastases","volume":"104","author":"K Imai","year":"2017","journal-title":"Br J Surg"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1055\/s-0032-1332997","article-title":"Therapie von Lebermetastasen des kolorektalen Karzinoms: \u00dcbersicht der hyperthermen Ablationsverfahren","volume":"138","author":"T Vogl","year":"2013","journal-title":"Dtsch Med Wochenschr"},{"key":"ref37","first-page":"1387","article-title":"Intra-arterial infusion of irinotecan-loaded drug-eluting beads (DEBIRI) versus intravenous therapy (FOLFIRI) for hepatic metastases from colorectal cancer: final results of a phase III study","volume":"32","author":"G Fiorentini","year":"2012","journal-title":"Anticancer Res"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"3649","DOI":"10.1002\/cncr.29534","article-title":"Randomized controlled trial of irinotecan drug\u2010eluting beads with simultaneous FOLFOX and bevacizumab for patients with unresectable colorectal liver\u2010limited metastasis","volume":"121","author":"R C Martin","year":"2015","journal-title":"Cancer"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1093\/annonc\/mdw235","article-title":"ESMO consensus guidelines for the management of patients with metastatic colorectal cancer","volume":"27","author":"E Van Cutsem","year":"2016","journal-title":"Ann Oncol"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1016\/j.semradonc.2018.06.009","article-title":"A Contemporary Update on the Role of Stereotactic Body Radiation Therapy (SBRT) for Liver Metastases in the Evolving Landscape of Oligometastatic Disease Management","volume":"28","author":"T P Robin","year":"2018","journal-title":"Semin Radiat Oncol"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.ctro.2020.11.014","article-title":"Marker-less online MR-guided stereotactic body radiotherapy of liver metastases at a 1.5 T MR-Linac \u2013 Feasibility, workflow data and patient acceptance","volume":"26","author":"C Gani","year":"2021","journal-title":"Clin Transl Radiat Oncol"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.ijrobp.2017.12.288","article-title":"Local Control After Stereotactic Body Radiation Therapy for Liver Tumors","volume":"110","author":"N Ohri","year":"2021","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1200\/jco.2015.66.1181","article-title":"SIRFLOX: Randomized Phase III Trial Comparing First-Line mFOLFOX6 (Plus or Minus Bevacizumab) Versus mFOLFOX6 (Plus or Minus Bevacizumab) Plus Selective Internal Radiation Therapy in Patients With Metastatic Colorectal Cancer","volume":"34","author":"G A van Hazel","year":"2016","journal-title":"J Clin Oncol"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"e617","DOI":"10.1016\/j.clcc.2018.06.001","article-title":"Effect of Primary Tumor Side on Survival Outcomes in Untreated Patients With Metastatic Colorectal Cancer When Selective Internal Radiation Therapy Is Added to Chemotherapy: Combined Analysis of Two Randomized Controlled Studies","volume":"17","author":"P Gibbs","year":"2018","journal-title":"Clin Colorectal Cancer"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.1002\/bjs.11283","article-title":"Secondary technical resectability of colorectal cancer liver metastases after chemotherapy with or without selective internal radiotherapy in the randomized SIRFLOX trial","volume":"106","author":"B Garlipp","year":"2019","journal-title":"Br J Surg"}],"container-title":["DMW - Deutsche Medizinische Wochenschrift"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/a-1391-5273.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,6]],"date-time":"2021-11-06T00:05:02Z","timestamp":1636157102000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/a-1391-5273"}},"subtitle":["Multimodale, interdisziplin\u00e4re Konzepte"],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":44,"journal-issue":{"issue":"22","published-online":{"date-parts":[[2021,11,5]]},"published-print":{"date-parts":[[2021,11]]}},"URL":"https:\/\/doi.org\/10.1055\/a-1391-5273","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["0012-0472","1439-4413"],"issn-type":[{"value":"0012-0472","type":"print"},{"value":"1439-4413","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11]]}}}